More about Science

Choose a therapeutic area to find related scientific content

Diabetes

Neurology

Rare Diseases

Rare Blood Disorders

Explore Content

Explore the most recently added content

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

 

Support for your Patients

Discover the selection of support materials for patients from different therapeutic areas

Our Products

AUBAGIO
teriflunomide

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v3.0)
Date of preparation: August 2022

FABRAZYME
agalsidase beta

Prescribing Information UK

MAT-GB-2105812 (v2.0)
Date of preparation: August 2022

LANTUS
insulin glargine

Prescribing Information UK

MAT-XU-2201444 (v2.0)
Date of preparation: August 2022

LEMTRADA
Alemtuzumab

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

MYOZYME
alglucosidase alfa

Prescribing Information UK

MAT-GB-2105179 (v3.0)
Date of preparation: August 2022

TOUJEO
insulin glargine

Prescribing Information UK

MAT-GB-2105435 (v2.0)
Date of preparation: August 2022

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.

MAT-GB-2105264 (v3.0) ​​​​​​
Date of preparation: September 2022